# Highlights From the American College of Cardiology's 2026 Scientific Sessions

Page: https://stenobird.com/podcast/jama-medical-news-779603/highlights-from-the-american-college-of-cardiology-s-2026-scientific-sessions
Text version: https://stenobird.com/podcast/jama-medical-news-779603/highlights-from-the-american-college-of-cardiology-s-2026-scientific-sessions.md
Podcast: [JAMA Medical News](https://stenobird.com/podcast/jama-medical-news-779603)
Published: 2026-04-10T15:00:00+00:00
Episode link: https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2026.2401
Audio file: https://traffic.libsyn.com/secure/jamamedicalnews/Highlights_From_the_American_College_of_Cardiologys_2026_Scientific_Sessions_1.mp3?dest-id=525944
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/jama-medical-news-779603/episodes/highlights-from-the-american-college-of-cardiology-s-2026-scientific-sessions
Duration seconds: 1230

## Resource

Hear the latest on PCSK9 inhibitors, cardiorenal benefits of GLP-1 drugs, and other clinical research in this interview with Katie Berlacher, MD, MS, chair of this year's annual ACC meeting. Related Content: PCSK9 Inhibitors in Diabetes, Tirzepatide's Cardiorenal Effects, Shingles Vaccine, and More From ACC

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/jama-medical-news-779603/episodes/highlights-from-the-american-college-of-cardiology-s-2026-scientific-sessions/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/jama-medical-news-779603/highlights-from-the-american-college-of-cardiology-s-2026-scientific-sessions.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.